Evidence map›Paper›PMID 40087146›Full record

ArticleHead & neck2025

Vision Changes After Head and Neck Cancer Treatment.

Hsiao-Lan Wang, Megan Heskett, Peng Li, Laura Dreer, David Vance, Susan McCammon, Kailei Yan, Amanda Elliott

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Head & neck, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hsiao-Lan WangUniversity of Alabama at Birmingham, Birmingham, Alabama, USA.ORCID 0000-0003-1594-2415
Megan HeskettUniversity of South Florida, Tampa, USA.
Peng LiUniversity of Alabama at Birmingham, Birmingham, Alabama, USA.
Laura DreerUniversity of Alabama at Birmingham, Birmingham, Alabama, USA.
David VanceUniversity of Alabama at Birmingham, Birmingham, Alabama, USA.
Susan McCammonUniversity of Alabama at Birmingham, Birmingham, Alabama, USA.
Kailei YanUniversity of South Florida, Tampa, USA.
Amanda ElliottUniversity of South Florida, Tampa, USA.

Funding

University of South Florida
6 · The paper itself

Abstract

backgroundLiterature about ocular toxicity after head and neck cancer (HNC) treatment is scarce. This study aimed to describe visual function and ocular symptoms among HNC patients.

methodsThe study used a cross-sectional design. Two surveys, The National Eye Institute Visual Functioning Questionnaire (NEI-VFQ) and an Ocular Symptom Scale, were sent to participants via e-mail. Descriptive statistics were used to describe the sample in the vision change and non-vision change groups. Chi-square and t-tests were used to compare groups.

resultsOf the 485 HNC patients emailed, 126 responded to the survey (26%). Of those, 114 completed the surveys. The scores of NEI-VFQ were significantly lower in the vision change group than in the non-vision change group (p < 0.001). Similarly, all ocular symptoms were significantly different between the two groups (p < 0.05).

conclusionsThese findings and a scarcity of literature suggest that vision screening after HNC treatment is warranted.

Indexed as

Head and Neck NeoplasmsVision DisordersAdultAgedCross-Sectional StudiesFemaleHumansMaleMiddle AgedQuality of LifeSurveys and Questionnaireshead and neck cancerNational Eye Institute's Visual Function Questionnaireocular symptomsvision changevisual function

Identifiers

PMID40087146
PMCPMC12248266

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.